Triorganotin(IV) derivatives of umbelliferone (7-hydroxycoumarin) and their adducts with 1,10-phenanthroline: synthesis, structural and biological studies

New triorganotin(IV) derivatives of the general formula R₃Sn(Umb) (where, R = Me, n-Bu and Ph; Umb = umbelliferone anion) have been synthesized using sodium salt method. Further, the adducts of the general formula R₃Sn(Umb) · phen (where R = Me and Ph; phen = 1,10-phenanthroline) have also been synthesized by the interaction of the triorganotin(IV) derivatives of umbelliferone with 1,10-phenanthroline. The bonding and coordination behavior of these derivatives are discussed on the basis of IR, NMR (¹H, ¹³C and ¹¹⁹Sn), and ¹¹⁹Sn Mössbauer spectroscopic studies. These investigations indicate that umbelliferone acts as a monoanionic bidentate ligand in R₃Sn(Umb) coordinating through O(7) and O(1) in the solid-state. These polymeric R₃Sn(Umb) derivatives (where R = Me and n-Bu) have been proposed to have a trans-trigonal bipyramidal geometry with the three R groups in equatorial positions, while the axial positions are occupied by a phenolic oxygen and the O(1) atom from the adjacent molecule. A pseudotetrahedral geometry has been suggested for Ph₃Sn(Umb). A distorted octahedral geometry around tin has been proposed for R₃Sn(Umb) · phen, in which umbelliferone anion acts as a monodentate ligand coordinating through phenolic oxygen O(7). The newly synthesized derivatives have been assayed for their anti-inflammatory, cardiovascular and anti-microbial activities. The average LD₅₀ values >1000 mg kg⁻¹ of these derivatives indicate their safety margin. Among all the compounds tested, Ph₃Sn(Umb) · phen has been found to show potent anti-inflammatory activity with low mammalian toxicity and mild hypotensive activity.     

Structural investigations on diorgano- and triorganotin(IV) derivatives of [meso-tetra(4-sulfonatophenyl)porphine] metal chlorides

Several new complexes of organotin(IV) moieties with MCl_n[meso-tetra(4-sulfonatophenyl)porphine], (R₂Sn)₂MCl_n[meso-tetra(4-sulfonatophenyl)-porphinate]s and (R₃Sn)₄MCl_n [meso-tetra(4-sulfonatophenyl)porphinate]s, [M = Fe(III), Mn(III): n = 1, R = Me, n-Bu; Ph; M = Sn(IV): n = 2, R = Me, n-Bu] have been synthesized and their solid state configuration investigated by infrared (IR) and Mössbauer spectroscopy, and by ¹H and ¹³C NMR in D₂O.The electron density on the metal ion coordinated inside the porphyrin ring is not influenced by the organotin(IV) moieties bonded to the oxygen atoms of the side chain sulfonatophenyl groups, as it has been inferred on the basis of Mössbauer spectroscopy and, in particular, from the invariance of the isomer shift of the Fe(III) and Sn(IV) atoms coordinated into the porphyrin square plane of the newly synthesized complexes, with respect to the same atoms in the free ligand.As far as the coordination polyhedra around the peripheral tin atoms are concerned, infrared spectra and experimental Mössbauer data would suggest octahedral and trigonal bipyramidal environments around tin, in polymeric configurations obtained, respectively, in the diorganotin derivatives through chelating or bridging sulfonate groups coordinating in the square plane, and in triorganotin(IV) complexes through bridging sulfonate oxygen atoms in axial positions.The structures of the (Me₃Sn)₄Sn(IV)Cl₂[meso-tetra(4-sulfonatophenyl)porphinate] and of the two model systems, Me₃Sn(PS)(HPS) and Me₂Sn(PS)₂ [HPS = phenylsulfonic acid], have been studied by a two layer ONIOM method, using the hybrid DFT B3LYP functional for the higher layer, including the significant tin environment. This approach allowed us to support the structural hypotheses inferred by the IR and Mössbauer spectroscopy analysis and to obtain detailed geometrical information of the tin environment in the compounds investigated.¹H and ¹³C NMR data suggested retention of the geometry around the tin(IV) atom in D₂O solution.     

New di- and triorganotin(IV) derivatives of tyrosinylphenylalanine as models for metal-protein interactions: Synthesis and structural characterization. Crystal structure of Me2Sn(Tyr-Phe) · MeOH

New di- and triorganotin(IV) derivatives of tyrosinylphenylalanine (H₂Tyr-Phe) with general formulae R₂Sn(Tyr-Phe) where R = Me,n-Bu, n-Oct and Ph, and R₃^′Sn(HTyr-Phe) where R^′ = Me and Ph have been synthesized. The bonding and coordination behaviour in these derivatives are discussed on the basis of FT-IR, multinuclear ¹H, ¹³C and ¹¹⁹Sn NMR and ¹¹⁹Sn Mössbauer spectroscopic studies. These investigations suggest that dipeptide in R₂Sn(Tyr-Phe) acts as dianionic tridentate coordinating through −C(O)O⁻, -NH₂ and (-CO)N⁻_peptide groups while in case of R^′₃Sn(HTyr-Phe) the ligand acts as monoanionic bidentate coordinating through -C(O)O⁻ and -NH₂, and the polyhedron around tin in R₂Sn(Tyr-Phe) and R^′₃Sn(HTyr-Phe) is a distorted trigonal-bipyramidal. It is further confirmed by the single crystal X-ray structure of Me₂Sn(Tyr-Phe) · MeOH which shows two methyl groups and peptide nitrogen (N⁻_peptide) in the equatorial positions, while the two axial positions are occupied by the carboxylic oxygen (O⁻_carboxyl) and the amino nitrogen (N_amino) atom from the same ligand molecule. One methanol molecule is also present in the asymmetric unit.     

Synthesis and solid-state spectroscopic investigation of some novel diorganotin(IV) complexes of tetraazamacrocyclic ligands

The tetradendate macrocyclic ligands, [H₂L-1 = 5,12-dioxa-7,14-dimethyl-1,4,8,11-tetraazacyclotetradeca-1,8-diene] and [H₂L-2 = 6,14-dioxa-8,16-dimethyl-1,5,9,13-tetraazacyclohexadeca-1,9-diene] have been prepared by the condensation reaction of 1,2-diaminoethane and 1,3-diaminopropane, respectively, with ethyl acetoacetate in methanol at room temperature. The diorganotin(IV) complexes of general formula [R₂Sn(L-1)/R₂Sn(L-2)] (R = Me, n-Bu and Ph) have been synthesized by template condensation reaction of 1,2-diaminoethane or 1,3-diaminopropane and ethyl acetoacetate with R₂SnCl₂ (R = Me or Ph) or n-Bu₂SnO in 2:2:1 molar ratio at ambient temperature (35 ± 2 °C) in methanol. The solid-state characterization of resulting complexes have been carried out by elemental analysis, IR, recently developed DART-mass, solid-state ¹³C NMR, ^119mSn Mössbauer spectroscopic studies. These studies suggest that in all of the studied complexes, the macrocyclic ligands act as tetradentate coordinating through four nitrogen atoms giving a skew-trapezoidal bipyramidal environment around tin center. Since, the studied diorganotin(IV) macrocyclic complexes are insoluble in common organic solvents, hence good crystals could not be grown for single crystal X-ray crystallographic studies. Thermal studies of all of the studied complexes have also been carried out in the temperature range 0-1000 °C using TG, DTG and DTA techniques. The end product of pyrolysis is SnO₂ confirmed by XRD analysis.     

New di- and triorganotin(IV) complexes of tripodal Schiff base ligand containing three imidazole arms: Synthesis, structural characterization, anti-inflammatory activity and thermal studies

Some new tri- and diorganotin(IV) complexes of the general formula, R₃Sn(H₂L) and R′₂Sn(HL) [where R = Me, n-Pr, n-Bu and Ph; R′ = Me, n-Bu, Ph and n-Oct; H₃L = Schiff base (abbreviated as tren(4-Me-5-ImH)₃) derived from condensation of tris(2-aminoethyl)amine (tren) and 4-methyl-5-imidazolecarboxaldehyde (4-Me-5-ImH)] have been synthesized. The coordination behaviour of Schiff base towards organotin(IV) moieties is discussed on the basis of infrared and far-infrared, ¹¹⁹Sn Mössbauer and multinuclear (¹H, ¹³C and ¹¹⁹Sn) magnetic resonance (NMR) spectroscopic studies. Thermal studies of all of the synthesized organotin(IV) complexes have been carried out using TG, DTG and DTA techniques. The residues thus obtained from pyrolysis of the studied complexes have been characterized by X-ray powder diffraction analysis and IR. The newly synthesized complexes have been tested for their anti-inflammatory activity and toxicity (LD₅₀).     

Tin(IV) and organotin(IV) derivatives of bis(pyrazolyl)acetate: Synthesis, spectroscopic characterization and behaviour in solution.: X-ray single crystal study of bis(pyrazol-1-yl)acetatotri-iodotin(IV) [SnI3(bdmpza)]

Novel heteroscorpionate-containing tin and organotin(IV) complexes, [SnR_nX_3 − n(L)], R = Me, Buⁿ, Ph, or cy; X = Cl, Br or I, n = 0, 1, 2 or 3; L = bis(pyrazol-1-yl)acetate (bpza) or bis(3,5-dimethylpyrazol-1-yl)acetate (bdmpza), have been synthesized and characterized by spectral (IR, ¹H, ¹³C and ¹¹⁹Sn NMR, ^119mSn Mössbauer) and analytical data. In [SnI₃(bdmpza)], the ligand is fac-N,N′,O-tridentate, the three iodine atoms thus also fac about the six-coordinate tin(IV) atom. Neutral bpzaH reacts with BuⁿSnCl₃, PhSnCl₃ and SnCl₄ in Et₂O in the absence of base, yielding 1:1 adducts [XSnCl₃(bpzaH)] (X = R or Cl).     

Structural characterization of triorganotin(IV) complexes with sodium fusidate and DFT calculations

Three new complexes of the steroid sodium fusidate (sodium 2-[(1S,2S,5R,6S,7S,10S,11S,13S, 14Z,15R,17R)-13-(acetyloxy)-5,17-dihydroxy-2,6,10,11-tetramethyl tetracyclo[8.7.0.0^2,7.0^11,15] heptadecan-14-ylidene]-6-methylhept-5-enoate = (NaFusidate, NaFA)]), with triorganotin(IV) moieties have been prepared and investigated by conventional techniques as FTIR, Mössbauer, ESI-MS and NMR spectroscopy. The isolated compounds showed stoichiometries organotin(IV)/fusidate 1/1, R₃Sn(IV)FA (R = Me, FA1; Bu, FA2; Ph, FA3). The ligand coordination sites were determined by FTIR spectroscopic measurements. In the complexes, the carboxylate group of the fusidate ligand behaves as monodentate monoanionic donor, binding the Sn(IV) through one oxygen atom.On the basis of C-Sn-O_COO angles, calculated through the rationalization of the ¹¹⁹Sn Mössbauer parameter nuclear quadrupole splitting, it has been confirmed that, in all the solid state complexes, the Sn(IV) was tetracoordinated in a distorted tetrahedral structure.Further data from ¹¹⁹Sn CP-MAS spectra confirmed the distorted tetrahedral arrangement.In MeOH solution, ¹H, ¹³C and ¹¹⁹Sn NMR spectroscopy showed monomeric complexes, where the carboxylate group mainly acts as monodentate ester-type ligand, and the occurrence of a coordinated solvent molecule to the tin center, as validated by non-relativistic NMR DFT study.     

Di-n-octyltin(IV) complexes with 5-[(E)-2-(aryl)-1-diazenyl]-2-hydroxybenzoic acid: Syntheses and assessment of solid state structures by Sn Mössbauer and X-ray diffraction and further insight into the solution structures using electrospray ionization MS, Sn NMR and variable temperature NMR spectroscopy

Reactions of 5-[(E)-2-(aryl)-1-diazenyl]-2-hydroxybenzoic acids (LHH′, where the aryl group is an R-substituted phenyl ring such that for L¹HH′: X = H; L²HH′: X=2′-OCH₃; L³HH′: X = 3′-CH₃; L⁴HH′: X = 4′-CH₃; L⁵HH′:X = 4′-Cl) with ⁿOct₂SnO in 2:1 and 1:1 molar ratios have been investigated. Two types of complexes, ⁿOct₂Sn(LH)₂ and {[ⁿOct₂Sn(LH)]₂O}₂, were isolated and they have been characterized by ¹H, ¹³C, ¹¹⁹Sn NMR, ESI-MS, IR and ^119mSn Mössbauer spectroscopic techniques in combination with elemental analyses. The crystal structures of ⁿOct₂Sn(L¹H)₂ (1), {[ⁿOct₂Sn(L²H)]₂O}₂ (3) and {[ⁿOct₂Sn(L³H)]₂O}₂(4) were determined. The mononuclear complex 1 was found to adopt a skew-trapezoidal bipyramidal arrangement around the tin atom while 3 and 4 are centrosymmetric tetranuclear bis(dicarboxylatotetrabutyldistannoxane) complexes containing a planar Sn₄O₂ core in which two μ₃-oxo O-atoms connect an Sn₂O₂ ring to two exocyclic Sn-atoms. The solution structures were confirmed by ¹¹⁹Sn NMR spectroscopy by observing one tin resonance in compound 1 and two tin resonances in {[ⁿOct₂Sn(L⁵H)]₂O}₂ (5). {[ⁿOct₂Sn(L²H)]₂O}₂ (3) and {[ⁿOct₂Sn(L³H)]₂O}₂ (4) undergo very complex exchange processes in deuteriochloroform solution, which has been confirmed by variable temperature ¹H NMR spectroscopy. The cleavage of the most labile bond in the molecule was studied by ESI mass spectrometry.     

Re-visiting of 5-[(E)-2-(aryl)-1-diazenyl]-quinolin-8-ol with tweaking of Sn-Ph groups: Synthesis, spectroscopic characterization and X-ray crystallography

Reactions of sodium 5-[(E)-2-(aryl)-1-diazenyl]quinolin-8-olates (LH, where the aryl group is an R-substituted phenyl ring such that for L¹H: R = H; L²H: R = 2′-CH₃; L³H: R = 3′-CH₃; L⁴H: R = 4′-CH₃; L⁵H: R = 4′-OCH₃ and L⁶H: R = 4′-OC₂H₅) with Ph₃SnCl in a 1:1 molar ratio yielded complexes of composition Ph₃SnL. The complexes have been characterized by ¹H, ¹³C, ¹¹⁹Sn NMR, IR and ^119mSn Mössbauer spectroscopic techniques in combination with elemental analyses. The crystal structures of Ph₃SnL¹ · 0.5C₆H₆ (1), Ph₃SnL² (2), Ph₃SnL⁵ · C₆H₆ (5) and Ph₃SnL⁶ · 0.5C₆H₆ (6) were determined. The results of the X-ray studies indicated that the benzene solvated compounds 1, 5 and 6 are distorted square pyramid, with one of the phenyl C atoms in the apex while the ligand arrangement around central Sn atom in 2 is distorted trigonal-bipyramidal, with a phenyl C and the oxinato N atoms in axial positions.     

Structure and spectroscopy of diorganotin(IV) complexes derived from N′-(2-hydroxy-3-methoxybenzylidene)benzohydrazide

Three new diorganotin(IV) complexes of the general formula R₂Sn[3-(OMe)-2-OC₆H₃CHN-NC(O)Ph] (R = Ph, Ia; R = Me, Ib; R = n-Bu, Ic) have been synthesised from the corresponding diorganotin(IV) dichlorides and the ligand, N′-(2-hydroxy-3-methoxybenzylidene)benzohydrazide in methanol at room temperature in the presence of trimethylamine. All the complexes have been characterized by elemental analysis, IR and ¹H, ¹³C, ¹⁵N, ¹¹⁹Sn NMR spectra, and their structures have been confirmed by single crystal X-ray diffraction analysis of one representative compound Ia. Complex Ia crystallises in the orthorhombic system, space group Pna2₁ with a = 12.424(5), b = 9.911(5), c = 18.872(5) Å; Z = 4. The ligand N′-(2-hydroxy-3-methoxybenzylidene)benzohydrazide (H₂L) coordinates to the metal centre in the enolate form via the phenolic O, imino N and enolic O atoms. In Ia, the central tin atom adopts a distorted trigonal bipyramidal coordination geometry with the oxygen atoms in axial positions, while the imino nitrogen atom of the Schiff base and the two phenyl groups occupy the equatorial sites. The δ(¹¹⁹Sn) values for the complexes Ia, Ib and Ic are −327.3, −151.7 and −187.2 ppm, respectively, thus indicating penta-coordinated Sn centres in solution.     

Investigation on coordination modes of organotin(IV) complexes with 6-thiopurine and related ligands

The organotin(IV) complexes R₂Sn(tpu)₂ · L [L = 2MeOH, R = Me (1); L = 0: R = n-Bu (2), Ph (3), PhCH₂ (4)], R₃Sn(Hthpu) [R = Me (5), n-Bu (6), Ph (7), PhCH₂ (8)] and (R₂SnCl)₂ (dtpu) · L [L = H₂O, R = Me (9); L = 0: R = n-Bu (10), Ph (11), PhCH₂ (12)] have been synthesized, where tpu, Hthpu and dtpu are the anions of 6-thiopurine (Htpu), 2-thio-6-hydroxypurine (H₂thpu) and 2,6-dithiopurine (H₂dtpu), respectively. All the complexes 1-12 have been characterized by elemental, IR, ¹H, ¹³C and ¹¹⁹Sn NMR spectra analyses. And complexes 1, 2, 7 and 9 have also been determined by X-ray crystallography, complexes 1 and 2 are both six-coordinated with R₂Sn coordinated to the thiol/thione S and heterocyclic N atoms but the coordination modes differed. As for complex 7 and 9, the geometries of Sn atoms are distorted trigonal bipyramidal. Moreover, the packing of complexes 1, 2, 7 and 9 are stabilized by the hydrogen bonding and weak interactions.     

Spectroscopic studies of biologically active organotin(IV) derivatives of 2-[N-(2,4,6-tribromophenylamido]propanoic acid

Herein we describe the synthesis and characterization of compounds having the formulae R₂SnL₂ and R₃SnL, where R = Me, n-Bu, Ph and n-Oct and L = 2-[N-(2,4,6-tribromophenylamido]propanoic acid. All the complexes have been characterized by various spectroscopic methods (IR and ¹H, ¹³C, ¹¹⁹Sn NMR), elemental analysis, mass spectrometry and physical data. These compounds were also screened for their biological activity and found some encouraging results.     

Self-assembly of diorganotin(IV) 2-{[(E)-1-(2-oxyaryl)alkylidene]amino}acetates: An investigation of structures by X-ray diffraction, solution and solid-state tin NMR, and electrospray ionization MS

The diorganotin(IV) compounds, [Me₂SnL²(OH₂)]₂ (1), [ⁿBu₂SnL²(OH₂)]₂ (2), [ⁿBu₂SnL¹]₃ · 0.5C₃H₆O (3), [ⁿBu₂SnL³]₃ · 0.5C₆H₆ (4) and [Ph₂SnL³]_n · 0.5C₆H₆ (5) (L = carboxylic acid residue, i.e., 2-{[(E)-1-(2-oxyaryl)alkylidene]amino}acetate), were synthesized by treating the appropriate diorganotin(IV) dichloride with the potassium salt of the ligand in anhydrous methanol.The reaction of Ph₂SnL² (L = 2-{[(E)-1-(2-oxyphenyl)ethylidene]amino}acetate) with 1,10-phenanthroline (Phen) yielded a 1:1 adduct of composition, [Ph₂SnL²(Phen)] (6).The crystal structures of 1-6 were determined.The crystal of 1 is composed of centrosymmetric dimers of the basic Me₂SnL²(OH₂) moiety, where the two Sn-centres are linked by two asymmetric Sn-O?Sn bridges involving the carboxylic acid O atom of the ligand and a long Sn?O distance of 3.174(2) Å.The dimers are further linked into columns by hydrogen bonds.The coordination geometry about the Sn atom is a distorted pentagonal bipyramid with the two methyl groups in axial positions.The structure of 2 is similar.The same Sn atom coordination geometry is observed in compound 3, which is a cyclic trinuclear[ⁿBu₂SnL¹]₃ compound. Each Sn atom is coordinated by the phenoxide O atom, one carboxylate O atom and the imino N atom from one ligand and both the exo- and endo-carboxylate O atoms (mean Sn-O(exo): 2.35 Å; Sn-O(endo): 2.96 Å) from an adjacent ligand to form the equatorial plane, while the two butyl groups occupy axial positions. Compound 4 was found to crystallize in two polymorphic forms. The Sn-complex in both forms has a trinuclear [ⁿBu₂SnL³]₃ structural motif similar to that found in 3. In compound 5, distorted trigonal bipyramidal Ph₂SnL³ units are linked into polymeric cis-bridged chains by a weak Sn?O interaction (3.491(2) Å) involving the exocyclic O atom of the tridentate ligand of a neighboring Sn-complex unit. This interaction completes a highly distorted octahedron about the Sn atom, where the weakly coordinated exocyclic O atom and one phenyl group are trans to one another. In contrast, a monomeric distorted pentagonal bipyramidal geometry is found for adduct 6 where the Sn-phenyl groups occupy the axial positions. The solution and solid-state structures are compared by using ¹¹⁹Sn NMR chemical shift data. Compounds 1-6 were also studied using ESI-MS and their positive- and negative-ions mass fragmentation patterns are discussed.     

Synthesis, crystal structure and in vitro antitumor activity of carboxylate bridged dinuclear organotin(IV) complexes

Two novel dinuclear organotin(IV) complexes [n-Bu₂Sn(imda)(H₂O)]₂·Bipy (1) and [n-Bu₂Sn(imda)(H₂O)]₂·Phen (2) [H₂imda = iminodiacetic acid, Bipy = 2,2′-bipyridine and Phen = 1,10-phenanthroline] were synthesised and characterized employing IR, ¹H, ¹³C, ¹¹⁹Sn NMR, and ¹¹⁹Sn Mössbauer spectroscopic and elemental analyses. Single crystal X-ray crystallography of 1 has confirmed that it is a binuclear Sn(IV) species formed via carboxylate bridges where each metal adopted a seven coordinate distorted pentagonal bipyramidal geometry. The iminodiacetate dianion (imda²⁻) acts as a potential tridentate [N,O,O] carboxylate bridging ligand. The packing revealed that the additional α-diimine (Bipy or Phen) does not coordinate to metal ion. However, its presence in the crystal lattice as spacer helps for the formation of a supramolecular framework by bringing the two binuclear species close enough through extensive H-bonding. The in vitro cytotoxicity of compounds 1 and 2 indicate better results than cisplatin against three tumor cell lines investigated.     

Synthesis and characterization of the first diorganotin(IV) complexes containing mixed arylazobenzoic acids and having skew trapezoidal bipyramidal geometry

Three diorganotin(IV) complexes of the type, [R₂Sn(L^aH)(L^bH)] (R = ⁿBu or Me and, L^aH and L^bH are two different 5-[(E)-2-(aryl)-1-diazenyl]-2-hydroxybenzoate residues; a: aryl = 4′-Cl-(held constant) and b: aryl = 4′-Me or 4′-Br) have been prepared either by reacting ⁿBu₂SnO, L^aHH′ and L^bHH′ (1:1:1) in anhydrous toluene or by reacting Me₂SnCl₂, L^aHNa and L^bHNa (1:1:1) in anhydrous methanol. The products were characterized by microanalysis, IR, NMR (¹H, ¹³C, ¹¹⁹Sn) and ^119mSn Mössbauer spectroscopy. A full characterization of the structures of the complexes [ⁿBu₂Sn(L^aH)(L^bH)] (1 and 2) and [Me₂Sn(L^aH)(L^bH)] (3) in the solid state were accomplished by single crystal X-ray crystallography. These complexes were found to adopt the usual dicarboxylato structural type with a skew-trapezoidal bipyramidal arrangement around the tin atom.     

Diphenyltin(IV) complexes of the 5-[(E)-2-(aryl)-1-diazenyl]quinolin-8-olates: Synthesis and multinuclear NMR, Sn Mössbauer, electrospray ionization MS, X-ray characterization and assessment of in vitro cytotoxicity

A series of cis-bis{5-[(E)-2-(aryl)-1-diazenyl]quinolinolato}diphenyltin(IV) complexes have been synthesized and characterized by ¹H, ¹³C, ¹¹⁹Sn NMR, ESI-MS, IR and ^119mSn Mössbauer spectroscopic techniques in combination with elemental analysis. The structures of a ligand L⁶H (i.e., 5-[(E)-2-(4-ethoxyphenyl)-1-diazenyl]quinolin-8-ol) and three diphenyltin(IV) complexes, viz., Ph₂Sn(L¹)₂ · (CH₃)₂CO (1), Ph₂Sn(L⁴)₂ (4) and Ph₂Sn(L⁵)₂ (5) (L = 5-[(E)-2-(aryl)-1-diazenyl]quinolin-8-ol: aryl = phenyl - (L¹H); 4′-methylphenyl - (L⁴H) and 4′-bromophenyl - (L⁵H)) were determined by single crystal X-ray diffraction. In general, the complexes were found to adopt a distorted cis-octahedral arrangement around the tin atom. These complexes retain their solid-state structure in non-coordinating solvent as evidenced by ¹¹⁹Sn NMR spectroscopic results. The in vitro cytotoxicity of 1 is reported and compared with Ph₂Sn(Ox)₂ (Ox = deprotonated quinolin-8-ol) against seven well characterized human tumor cell lines.     

Self-assembly syntheses and crystal structures of triorganotin(IV) pyridinecarboxylate: 1D polymers and a 42-membered macrocycle

A series of new triorganotin(IV) pyridinecarboxylates with 6-hydroxynicotinic acid (6-OH-3-nicH), 5-hydroxynicotinic acid (5-OH-3-nicH) and 2-hydroxyisonicotinic acid (2-OH-4-isonicH) of the types: [R₃Sn (6-OH-3-nic)·L]_n (I) (R = Ph, L = Ph·EtOH, 1; R = Bn, L = H₂O·EtOH, 2; R = Me, L = 0, 3; R = n-Bu, L = 0, 4), [R₃Sn (5-OH-3-nic)]_n (II) (R = Ph, 5; R = Bn, 6; R = Me, 7; R = n-Bu, 8), [R₃Sn (2-OH-4-isonic·L)]_n (III) (R = Bn, 9, L = MeOH; R = Me, L = 0, 10; R = Ph, 11, L = 0.5EtOH) have been synthesized. All the complexes were characterized by elemental analysis, TGA, IR and NMR (¹H, ¹³C, ¹¹⁹Sn) spectroscopy analyses. Among them, except for complexes 5 and 6, all complexes were also characterized by X-ray crystallography diffraction analysis. Crystal structures show that complexes 1-10 adopt 1D infinite chain structures which are generated by the bidentate O, O or N, O and the five-coordinated tin centers. Significant O-H?O, and N-H?O intermolecular hydrogen bonds stabilize these structures. Complex 11 is a 42-membered macrocycle containing six tin atoms, and forms a 2D network by intermolecular N-H?O hydrogen.     

In vitro antitumor and antibacterial assay of organotin(IV) complexes of 2,3-methylenedioxybenzoic acid; X-ray crystal structure of [(C2H5)2Sn(C8H5O4)2]

New organotin(IV) compounds containing the carboxylate ligand 2,3-methylenedioxybenzoic acid (HL) have been synthesized with the general formula R₂SnL₂ (R = Me, Et, n-Bu, Ph and n-Oct) and R₃SnL (R = n-Bu). All compounds have been studied in the solution state by multinuclear NMR (¹H, ¹³C and ¹¹⁹Sn) by using the non-coordinating solvent and also in solid sate by FTIR, mass spectrometry and X-ray crystallography. Spectroscopic data have shown that methylenedioxy moiety does not coordinate with tin atom and the coordination site is actually -COO group, as is proved by X-ray structure determination. The solid state structure of compound (2) has been determined by X-ray crystallography which shows that the complex (2) has distorted octahedral geometry. These complexes have been evaluated in vitro against crown gall tumor and antibacterial activity. Interesting results were noticed during the bio-activity screenings, which proved their in vitro biological potential and possible use as drugs.     

Structural and spectral studies of 3-(2-hydroxyphenylimino)-1-phenylbutan-1-one and its diorganotin(IV) complexes

Two diorganotin(IV) complexes of the general formula R₂Sn[Ph(O)CCH-C(Me)N-C₆H₄(O)] (R = Ph, 1a; R = Me, 1b) have been synthesized from the corresponding diorganotin(IV) dichlorides and the ligand, 3-(2-hydroxyphenylimino)-1-phenylbutan-1-one (1) in methanol at room temperature in presence of triethylamine. Both compounds have been characterized by elemental analyses, IR and ¹H, ¹³C, ¹⁵N, ¹¹⁹Sn NMR spectra. The structures of the free ligand and the complexes have been confirmed by single crystal X-ray diffraction. There are three independent molecules in the crystal structure of the ligand 1 and in all three the O-bound proton is transferred to the imine nitrogen and makes an intramolecular N-H?O hydrogen bond with the carbonyl oxygen. In turn this makes an intermolecular hydrogen bond with the phenolic H atom. The crystal structure of 1 is trigonal and a new polymorph; triclinic and monoclinic forms have already been published. In 1a, the central tin atom adopts distorted trigonal-bipyramidal coordination geometry whereas in dimeric 1b it is distorted octahedral when including the intermolecular Sn-O(phenolic) bond [2.7998(20) Å]. The δ (¹¹⁹Sn) values for the complexes 1a and 1b are −306.6 and −127.9 ppm, respectively, thus indicating penta-coordinated Sn centres in solution.     

Dibenzyltin(IV) complexes of the 5-[(E)-2-(aryl)-1-diazenyl]quinolin-8-olates: Synthesis and an investigation of structures by X-ray diffraction, solution and solid-state tin NMR, Sn Mössbauer and electrospray ionization MS

A series of cis-bis{5-[(E)-2-(aryl)-1-diazenyl]quinolinolato}dibenzyltin(IV) complexes have been synthesized by reacting sodium salts of 5-[(E)-2-(aryl)-1-diazenyl]quinolin-8-ol (LH) and dibenzyltin dichloride. These complexes have been characterized by ¹H, ¹³C, ¹¹⁹Sn NMR, ESI-MS in solution and by IR and ^119mSn Mössbauer, ¹¹⁷Sn CP-MAS NMR spectroscopy in solid state. In addition, the structures of three of the dibenzyltin(IV) complexes, viz., Bz₂Sn(L²)₂ (2), Bz₂Sn(L³)₂ (3), and Bz₂Sn(L⁵)₂ (5) (L = 5-[(E)-2-(aryl)-1-diazenyl]quinolin-8-ol: aryl = 4′-methylphenyl- (L²H), 4′-methoxylphenyl- (L³H) and 4′-bromophenyl- (L⁵H)) were determined by single-crystal X-ray diffraction. In general, the complexes were found to adopt a distorted cis-octahedral arrangement around the tin atom in both solution and solid state.